N-BENZYL-MORPHOLINE DERIVATIVES AS MODULATORS OF THE CHEMOKINE RECEPTOR
申请人:AstraZeneca AB
公开号:EP1919884A1
公开(公告)日:2008-05-14
N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine Receptor
申请人:Luckhurst Christopher
公开号:US20090118288A1
公开(公告)日:2009-05-07
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
[EN] N-BENZYL-MORPHOLINE DERIVATIVES AS MODULATORS OF THE CHEMOKINE RECEPTOR<br/>[FR] DÉRIVÉS DE N-BENZYL-MORPHOLINE EN TANT QUE MODULATEURS DU RÉCEPTEUR DE CHIMIOKINE
申请人:ASTRAZENECA AB
公开号:WO2007011292A1
公开(公告)日:2007-01-25
[EN] The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state. [FR] La présente invention concerne un composé de formule (I) : selon cette formule, les variables sont définies ; pour un procédé de préparation d'un tel composé ; et pour l'utilisation d'un tel composé dans le traitement d'une maladie traitée par chimiokine (tel que le CCR3).